The observed enhanced HNRNPK expression in acute myeloid leukemia (AML) patients that develop drug resistance to treatment is associated with an increased basal level of autophagy, suggesting that HNRNPK might regulate the expression or alternative splicing of autophagy-related genes36. This evidence concerns the gene HNRNPK and acute myeloid leukemia.